Add BrightSurf on Google Email

American College of Cardiology


Two-drug combos using popular calcium channel blocker show superiority in lowering BP

A large randomized controlled trial found that two frontline two-drug combinations including amlodipine significantly reduced blood pressure levels more than a third combination without amlodipine. The study, conducted in sub-Saharan Africa, showed that nearly half of adults have high blood pressure, often receiving ineffective treatment.

SourceAmerican College of Cardiology·JournalNew England Journal of Medicine·DateMar 18, 2019

Pure omega-3 prescription drug markedly reduces first, repeat and total CV events

A new study shows that a 4 gram dose of icosapent ethyl significantly reduces the occurrence of ischemic events, including heart attacks, strokes, and related deaths. The drug also prevents subsequent cardiovascular events and may be a cost-effective way to prevent CV complications in patients with elevated triglycerides.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateMar 18, 2019

Medical bills financially burden almost half of cardiovascular disease patients

A study published in the Journal of the American College of Cardiology found that 45.1% of adult atherosclerotic cardiovascular disease (ASCVD) patients experience financial hardship due to medical bills. Insured and uninsured individuals, particularly those with lower incomes, are disproportionately affected.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateFeb 11, 2019

Key to lifelong heart health is childhood intervention

A review paper highlights the importance of infusing heart-healthy behaviors into all aspects of children's lives, starting from early childhood. The authors suggest that modifiable risk factors in children can be prevented by educating on healthy habits early in life, leading to similar health outcomes as those who were never unhealthy.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateDec 6, 2018

Donor hearts at increased disease risk offer better survival rates for transplant recipients

Researchers found that accepting an organ from a donor at higher risk of disease transmission offers a higher one-year survival rate for candidates on the heart transplant list. Patients who decline such offers may wait longer or become too ill to undergo the procedure, resulting in higher mortality rates.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateOct 29, 2018

Cancer survivors at risk for heart failure during, after pregnancy

Young women previously treated for cancer with cardiotoxic treatments are more likely to develop clinical congestive heart failure (CHF) during and after pregnancy. According to the study, there's approximately a 1 in 3 chance of developing CHF for women who have been exposed to cardiotoxic treatments and had prior cardiotoxicity.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateOct 15, 2018

AFib patients with cancer history less likely to see cardiologist, fill prescriptions

Patients with AFib and a history of cancer are more likely to experience suboptimal antithrombotic care, leading to increased risk of stroke. Cardiology providers play a crucial role in improving outcomes for these patients, according to a study published in the Journal of the American College of Cardiology.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateOct 8, 2018